Siemens’ Dx Quality Control Called Out In Three FDA Warning Letters
This article was originally published in The Gray Sheet
Executive Summary
The letters, based on inspections carried out at three different facilities between October 2011 and February 2012, cite numerous violations involving the firm’s complaint handling and other quality-control procedures.